In case you are wondering why I say COLOSTAT is dead in the water for many years, it comes after much research, emails and phone conversations with government departments etc. etc = can't disclose.
A TGA re-submission for COLOSTAT to be allowed on ARTG may or may not be successful but the hurdles it will have to overcome if successful are enormous to have any penetration and/or turn in profits (NO CHANCE to be truthful). No company worldwide makes profit from CRC blood tests, NOBODY!!!
COLOSTAT is years away (maybe even towards the end of the decade) from being accepted as a population screening test in Australia and NZ and for that matter overseas as well.
For what it's worth, SONIC and the Australian government have a contract in place to the value of approximately $123,000,000 to supply and analyse until beginning of January 2025.
It originally was to the value of around $32,000,000 which commenced in 2017. There have been around 4 amendments to the contract increasing to the amount above.
Not so easy to to change the paradigm. This is why I think you are all dreamers. Management too in my opinion, or are they not dreamers but something else?
RHY Price at posting:
47.5¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)